FINVX | TROZX | FINVX / TROZX | |
Total Expense Ratio | 0.01 | 0.00 | - |
Annual Report Gross Expense Ratio | 0.01 | 0.66 | 2% |
Fund Existence | 15 years | 5 years | - |
Gain YTD | 1.174 | 1.425 | 82% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.4B | 11.8B | 131% |
Annual Yield % from dividends | 4.09 | 3.18 | 128% |
Returns for 1 year | -0.59 | 3.48 | -17% |
Returns for 3 years | 23.83 | 28.06 | 85% |
Returns for 5 years | 96.43 | 84.58 | 114% |
Returns for 10 years | 48.46 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBTH | 22.46 | 0.02 | +0.09% |
iShares iBonds Dec 2027 Term Tr ETF | |||
VLU | 162.34 | -2.71 | -1.64% |
SPDR® S&P 1500 Value Tilt ETF | |||
ECML | 27.05 | -0.67 | -2.41% |
Euclidean Fundamental Value ETF | |||
BUZZ | 19.72 | -0.51 | -2.50% |
VanEck Social Sentiment ETF | |||
IBRN | 18.44 | -0.88 | -4.55% |
iShares Neuroscience and Healthcare ETF |